Become a Member
Dark Mode
Become a Member
Members Only
Latest News
PM Modi in US
Special Projects
Neon
FIT
Webqoof
My Report
Brand Studio
Indian Diaspora
Entertainment
Opinion
World
Videos
Podcasts
Sports
Law
More
Gender
Climate Change
FAQs
Explainers
Graphic Novels
Education
Quint Lab
Business
Good News
Members' Opinion
Photos
Dark Mode
Become a Member
Home
Elections
Jobs
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
Covaxin
Covishield Gives Higher Immune Response Than Covaxin, Finds New Study
Govt, Bharat Biotech Deny ‘Shortcut’ in Covaxin Trials: What's the Controversy?
ADVERTISEMENT
REMOVE AD
Covaxin Is Safe and Effective in Kids as Young as 2 Years: Lancet
Covaxin Approved for 6 -12 Year Old Kids, Say Reports: What to Know
COVID-19: WHO Suspends Supply of Bharat Biotech’s Covaxin Through UN
Covishield Booster After Two Covaxin Doses Increases Antibodies Six-fold: Study
Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in the US: Bharat Biotech
Covishield, Covaxin Get Regular Market Approval by DCGI: Report
DGCI Grants Conditional Market Approval for Covaxin & Covishield
Covaxin, Covishield Most Used COVID Jabs in India: What's the Status of Others?
Covishield, Covaxin Get Regular Market Authorisation: Report
Govt Panel Recommends Regular Market Approval for Covishield, Covaxin
Covishield Gives Higher Immune Response Than Covaxin, Finds New Study
Govt, Bharat Biotech Deny ‘Shortcut’ in Covaxin Trials: What's the Controversy?
Covaxin Is Safe and Effective in Kids as Young as 2 Years: Lancet
Covaxin Approved for 6 -12 Year Old Kids, Say Reports: What to Know
COVID-19: WHO Suspends Supply of Bharat Biotech’s Covaxin Through UN
Covishield Booster After Two Covaxin Doses Increases Antibodies Six-fold: Study
ADVERTISEMENT
REMOVE AD
Covaxin to Be Evaluated as COVID-19 Vaccine Candidate in the US: Bharat Biotech
Covaxin, Covishield Most Used COVID Jabs in India: What's the Status of Others?
Covishield, Covaxin Get Regular Market Approval by DCGI: Report
DGCI Grants Conditional Market Approval for Covaxin & Covishield
Covishield, Covaxin Get Regular Market Authorisation: Report
Govt Panel Recommends Regular Market Approval for Covishield, Covaxin
Load More
